Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 CAD | +2.86% | +9.09% | -2.70% |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Mar. 15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 62.65M 45.83M | Sales 2023 | 66.1M 48.35M | Capitalization | 10.41M 7.62M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.93M | Net income 2023 | - 0 | EV / Sales 2022 | 0.35 x |
Net Debt 2022 | 12.65M 9.25M | Net Debt 2023 | 8.94M 6.54M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-2.09
x | P/E ratio 2023 |
-95.3
x | Employees | 156 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.12% |
1 day | +2.86% | ||
1 week | +9.09% | ||
Current month | +5.88% | ||
1 month | +5.88% | ||
3 months | +2.86% | ||
6 months | +16.13% | ||
Current year | -2.70% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Walewicz
CEO | Chief Executive Officer | 55 | 20-06-24 |
Danish Baig
DFI | Director of Finance/CFO | - | 23-04-30 |
Jeff Zygouras
DFI | Director of Finance/CFO | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Walewicz
CEO | Chief Executive Officer | 55 | 20-06-24 |
Daniel Chicoine
CHM | Chairman | 70 | 20-06-24 |
Sasha Cucuz
BRD | Director/Board Member | 46 | 20-06-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.18 | +2.86% | 39,000 |
24-05-03 | 0.175 | +2.94% | 192,000 |
24-05-02 | 0.17 | 0.00% | 8,500 |
24-04-30 | 0.17 | +3.03% | 26,000 |
Delayed Quote Toronto S.E., May 06, 2024 at 10:34 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.70% | 7.2M | |
+14.55% | 80.61B | |
-29.12% | 70.18B | |
+11.76% | 29.12B | |
-11.55% | 16.97B | |
-0.71% | 16.96B | |
-1.62% | 15.26B | |
+4.35% | 12.41B | |
-30.88% | 11.95B | |
-5.39% | 11.93B |
- Stock Market
- Equities
- NPTH Stock